Trial · NCT01112358
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Oocytes Retrieved | At the end of stimulation (Day 2 up to Day 8) | |
| Primary | Number of Follicles Greater Than (>) 14 Millimeter (mm) in Diameter | At the end of stimulation (Day 2 up to Day 8) | |
| Primary | Oocytes Recovery Rate | At the end of stimulation (Day 2 up to Day 8) | Oocytes recovery rate (oocytes per \>14 mm follicle) is defined as number of oocytes retrieved divided by number of follicles \>14 mm in diameter. |
| Secondary | Oocyte Nuclear Maturity Rate | At the end of stimulation (Day 2 up to Day 8) | Oocyte nuclear maturity rate (metaphase II oocytes per retrieved oocyte) is defined as number of metaphase II oocytes divided by total number of oocytes retrieved. |
| Secondary | Fertilization Rate | Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8) | The fertilization rate (2 pronuclei \[PN\] fertilized oocytes per inseminated oocyte) was defined as number of 2 PN fertilized oocytes divided by number of inseminated oocytes. |
| Secondary | Number of Embryos by Quality | Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8) | Embryo quality was graded according to morphological classification of Veeck. Grade 1: even blastomeres with no fragmentation; Grade 2: even blastomeres with slight fragmentation (less than 20%); Grade 3: uneven size blastomeres with no fragmentation; Grade 4: even or uneven size blastomeres with moderate fragmentation (20-25%); and Grade 5: unrecognizable blastomeres with severe fragmentation (\>50%). |
| Secondary | Number of Embryos Transferred by In Vitro Fertilization (IVF) | Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8) | |
| Secondary | Number of Participants With Positive Pregnancy Test | Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8) | The beta Human Chorionic Gonadotropin (beta-hCG) test was used as pregnancy test. |
| Secondary | Number of Participants With Clinical Pregnancy | Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8) | A clinical pregnancy is a pregnancy that is confirmed by both pregnancy test (beta-hCG test) and sonographic confirmation of a gestational sac or heartbeat (fetal sac). |
| Secondary | Implementation Rate | Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8) | Implementation rate (clinical pregnancy/embryo transferred) was defined as the number of clinical pregnancies divided by number of embryos transferred. |
| Secondary | Plasma Level of Estradiol | At the time of r-hCG administration (any days between Day 2 to Day 8) | |
| Secondary | Endometrial Thickness | At the time of r-hCG administration (any days between Day 2 to Day 8) | |
| Secondary | Duration of Ovarian Stimulation | Randomization to Day 8 | Duration of ovarian stimulation was defined as the time from start of study treatment to time of r-hCG administration. |
| Secondary | rFSH Cumulative Dose | Randomization to Day 8 | |
| Secondary | Plasma Levels of LH | At the time of r-hCG administration (any days between Day 2 to Day 8) | |
| Secondary | Number of Participants in Whom At Least 1 Stimulation Cycle Was Cancelled | Randomization to Day 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01112358/registered